RenaissanceRe
-
The reinsurer said it was monitoring conditions in the property E&S markets, where it has been reducing capacity to grow in property treaty, as rate gains could provide fertile ground for future growth.
-
The Inside P&C news team runs you through the earnings results for the day.
-
Inside P&C’s news team runs you through the key highlights of the week.
-
Reinsurers have mostly grown since before the Covid crisis, but the type and timing of growth affects value creation,
-
Recent top line growth and improved performance will need to be weighed against historical underperformance at group level, but the opportunity could attract a non-traditional buyer.
-
Morgan Stanley and Golman Sachs exercised in full their right to buy 945,000 shares in the company.
-
Inside P&C’s news team runs you through the key highlights of the week.
-
The review will continue until the deal closes and the agency evaluates “organizational changes and strategic positioning within the new structure”.
-
The recent deal is accretive at 18% and will allow RenRe to take further advantage of the hard market.
-
The group exited an off-strategy business at an attractive valuation – now it must give a clearer indication of where it is going.
-
The carrier intends to use the cash raised as part of its consideration for Validus.
-
The deal is not predicted to have a long-term impact on RenRe’s financial leverage, AM Best said.
Related
-
RenRe appoints Riley as global casualty head
June 09, 2025 -
Q1 earnings roundup April 23: RenRe, Selective, RLI
April 23, 2025